This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes.
Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. We aimed to compare outcomes between a broad range of second-generation DP-DES and BP-DES in an all-comer population. Conclusion Clinical follow-up up to 2 years shows similar outcomes between BP-DES and DP-DES.
Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Results Among all patients (n = 38,671), 31% had stable CAD, and 69% suffered an acute myocardialinfarction.
A heart attack, or myocardialinfarction, happens when an artery becomes blocked, reducing blood flow to the heart muscle. Raising awareness and taking proactive steps can ensure the best possible outcomes for those at risk of heart-related conditions. What is a Heart Attack?
milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty. and Susan F.
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Circulation, Ahead of Print. 1.52]) or without (155/1634 [9.7%] versus 142/1655 [8.9%]; hazard ratio, 1.08 [95% CI, 0.86–1.36;PintHR=0.87)
A comparison of electrocardiographic changes during reperfusion of acute myocardialinfarction by thrombolysis or percutaneous transluminal coronary angioplasty. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardialinfarction. Am Heart J. 2000;139:430–436. Am J Cardiol.
I have seen cases of Wellens' syndrome that were ignored because of either negative troponins or normal echo or both and the patient did not get an angiogram and had a bad outcome. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardialinfarction. Am Heart J (1989) 117 : pp 657-665.
Electrocardiographic Manifestations: Acute posterior wall myocardialinfarction. Posterior myocardialinfarction: the dark side of the moon. New electrocardiographic criteria for posterior wall myocardial ischemia validated by percutaneous transluminal coronary angioplasty model of acute myocardialinfarction.
It is highly associated with proximal LAD occlusion and bad outcomes. See this article by Widimsky: Primary angioplasty in acute myocardialinfarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy [link]
Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardialinfarction: importance of microvascular reperfusion injury on clinical outcome. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.
to 10% of percutaneous coronary interventions (PCI), no-reflow is a complication associated with poor outcomes like myocardialinfarction extension and death. Circulation, Volume 150, Issue Suppl_1 , Page A4139207-A4139207, November 12, 2024. Background:Occurring in 0.6%
At the bottom of the post, I have re-printed the section on aVR in my article on the ECG in ACS from the Canadian Journal of Cardiology: New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute MyocardialInfarction in the Emergency Department Case 1. Widimsky P et al. O'Gara PT, Kushner FG, Ascheim DD, et al.
There was a good outcome. We believe this represents a form of “toxicomythology” given the millions of doses of beta -blockers administered in the past to patients with hyperadrenergic states, and a paucity of evidence of adverse outcomes (12). This would treat both SVT or sinus tachycardia. Later, he was found to have used cocaine.
Studies show that 30% of NonSTEMI have an occluded infarct artery at the time of angiography done 24 hours after presentation. These patients have worse outcomes: higher mortality, more CHF, higher biomarkers, and worse ejection fractions than the NonSTEMI patients with open arteries. This is because of subtle ECG findings.
Read our recent editorial: Hyperacute T-waves Can Be a Useful Sign of Occlusion MyocardialInfarction if Appropriately Defined. Do you think his long term outcome will be as good as if his OMI were recognized appropriately on arrival, 1.5 TIMI flow alone cannot be used as an outcome definition for OMI or STEMI. =
Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardialinfarction. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardialinfarction. Am Heart J. Am Heart J.
Soviet biologist Trofim Lysenko famously rejected the objective reality of Mendelian genetics because it clashed with the Marxist philosophy that the environment, not genetics, was the primary determinant of outcomes. But what should matter is outcomes not diagnoses. Physician assessments often misclassify chest pain as nonanginal.
Spontaneous coronary artery dissection Dissection of a coronary artery may occur in the context of atherosclerosis, or be iatrogennic during angiography or angioplasty. Outcome of our case Once the type 2 SCAD was identified, the heparin drip was stopped. This case occurred 10+ years ago. Lobo et al. The SCAD cases in Lobo et al.
Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardialinfarction patients. Her long term outcome (with very large LAD MI and EF of 30%) is unknown. Otherwise it results in a terrible outcome, as in this case, with devastating permanent loss of myocardium).
Full case details and outcomes are below. Next trop 85,528 ng/L (consistent with a massive myocardialinfarction), none further measured. Sean Rees MD, written by Pendell Meyers, other case by Sam Ghali and Steve Smith Take a look at these two ECGs below from two patients in the ED, first without any clinical context.
When one of these arteries becomes completely blocked by a blood clot, it results in a heart attack, also known as MI (Myocardialinfarction). When a person experiences a heart attack or myocardialinfarction, they may feel chest pain and other symptoms in different parts of their body.
The objective of this study was to determine whether PCI is associated with better outcomes, compared with medical therapy (MT) alone. Using the Swedish Coronary Angiography and Angioplasty Registry, we included all patients with CCS undergoing coronary angiography in Sweden between 2010 and 2020.
Initial diagnostics indicated non-ST-elevation myocardialinfarction, leading to immediate intervention. A combination of balloon angioplasty, stent implantation, and intra-arterial thrombolysis with recombinant tissue plasminogen activator (rt-PA) was employed, resulting in significant thrombus reduction and improved coronary flow.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content